A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non-small-cell lung cancer and melanoma

被引：0
|
作者：
Shaked, Yuval
Benguigui, Madeleine
Halaban, Ruth
Bacchiocchi, Antonella
Kamer, Iris
Bar, Jair
Lotem, Michal
Shen-Orr, Shai
Sznol, Mario
Cooper, Tim J.
机构：
[1] Technion, Haifa, Israel
[2] Technion Israel Inst Technol, Haifa, Israel
[3] Yale Sch Med, New Haven, CT USA
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Inst Oncol, Sheba Med Ctr, Ramat Gan, Israel
[6] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[7] Yale Univ, Yale New Haven Hosp, Smilow Canc Hosp, Yale Canc Ctr,Sch Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
欧洲研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2557
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study
    Cheng, Ching-Yuan
    Chuang, Wen-Chen
    Lin, Ching-Pin
    Li, Che-Hsing
    Chang, Hui-Yi
    Wu, Wen-Jun
    Wu, Ming-Fang
    Ko, Jiunn-Liang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [22] Predictive biomarker analysis of non-small cell lung cancer patients
    Sakellariou, S.
    Karatrasoglou, E. A.
    Chatziandreou, I.
    Giannopoulou, I.
    Michelli, M.
    Zougros, A.
    Rouppou, E.
    Stamopoulos, K.
    Lazaris, A. C.
    Korkolopoulou, P.
    Saetta, A.
    VIRCHOWS ARCHIV, 2019, 475 : S105 - S105
  • [23] Recent advances in immunotherapy for non-small-cell lung cancer
    Suzuki, Hiroyuki
    Owada, Yuki
    Watanabe, Yuzuru
    Inoue, Takuya
    Fukuharav, Mitsuro
    Yamaura, Takumi
    Mutoh, Satoshi
    Okabe, Naoyuki
    Yaginuma, Hiroshi
    Hasegawa, Takeo
    Yonechi, Atsushi
    Ohsugi, Jun
    Hoshino, Mika
    Higuchi, Mitsunori
    Shio, Yutaka
    Gotoh, Mitsukazu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (02) : 352 - 357
  • [24] Targeted therapies and immunotherapy in non-small-cell lung cancer
    Cortinovis, D.
    Abbate, M.
    Bidoli, P.
    Capici, S.
    Canova, S.
    ECANCERMEDICALSCIENCE, 2016, 10
  • [25] Immunotherapy combinations emerging in non-small-cell lung cancer
    Chao, Yvonne L.
    Pecot, Chad V.
    IMMUNOTHERAPY, 2018, 10 (08) : 627 - 629
  • [26] Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer
    Cascone, Tina
    Fradette, Jared
    Pradhan, Monika
    Gibbons, Don L.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2022, 12 (05):
  • [27] Quantifying the benefit of non-small-cell lung cancer immunotherapy
    Ludmir, Ethan B.
    Mccaw, Zachary R.
    Grossberg, Aaron J.
    Wei, Lee-jen
    Fuller, C. David
    LANCET, 2019, 394 (10212): : 1904 - 1904
  • [28] Perioperative immunotherapy for resectable non-small-cell lung cancer
    Xiaodong Yang
    Dongliang Bian
    Jie Yang
    Liang Duan
    Haifeng Wang
    Deping Zhao
    Gening Jiang
    Yuming Zhu
    Peng Zhang
    Clinical Cancer Bulletin, 3 (1):
  • [29] Immunotherapy in advanced non-small-cell lung cancer withEGFRmutations
    Liu, Fangfang
    Yuan, Xun
    Jiang, Jizong
    Chu, Qian
    IMMUNOTHERAPY, 2020, 12 (16) : 1195 - 1207
  • [30] Potential biomarkers for immunotherapy in non-small-cell lung cancer
    Wang, Xing
    Qiao, Ziyun
    Aramini, Beatrice
    Lin, Dong
    Li, Xiaolong
    Fan, Jiang
    CANCER AND METASTASIS REVIEWS, 2023, 42 (03) : 661 - 675
12345